To determine whether the product of the recently cloned ob gene functions as an adiposerelated satiety factor, recombinant murine ob protein was administered intraperitoneally to ob/ob mice. Monomeric ob protein given as single morning injections to groups of three animals at seven doses ranging from 5 to 100 micrograms reduced 24-h chow consumption in a dose-dependent manner from values of 81 +/-6.8% of control (10-micrograms dose, P = 0.04) to 29 +/-7.7% of control (100-micrograms dose, P < 0.0001). Daily injections of 80 micrograms of ob protein into six ob/ob mice for 2 wk led to an 11 +/-1.6% decrease in body weight (P = 0.0009) and suppressed feeding to 26 +/-4.9% of baseline (P < 0.0001), with significant reduction of serum insulin and glucose levels. The effect of recombinant ob protein on feeding was not augmented by cofactors secreted by adipose tissue, nor did exposure of adipose tissue to ob protein affect intracellular ob mRNA levels. Posttranslational modification of ob protein was not required for activity; however, addition of a hexahistidine tag to the amino terminus of the mature ob protein resulted in prolonged suppression of feeding after injection into ob/ob mice. These results demonstrate a direct effect of the ob protein to suppress feeding in the ob/ob mouse and suggest that this molecule plays […] 
Introduction
Obesity is a major public health problem that contributes significantly to cardiovascular morbidity and mortality in the United States and other developed countries (1, 2) . Treatment of this condition is generally unsuccessful due to the operation of physiological mechanisms that restore adipose mass to baseline after intentional or unintentional changes (3) (4) (5) . A particularly important mechanism acting to stabilize body fat content is the decrease in appetite and caloric intake that accompanies any increase in total adipose mass (6) . In 1953 Kennedy postulated that this inverse relationship was due to a satiety signal transmitted by adipose tissue to feeding centers in the central nervous system (7) . Hervey provided evidence for the presence of such a signal in the circulation of parabiotic rats (8) , and Coleman demonstrated that defects in this signaling pathway could account for obesity in ob/ob and db/db mouse models (9, 10) . Despite the plausibility of the Kennedy hypothesis, there has been only limited direct evidence for the production and secretion of a satiety factor by adipose tissue (11, 12) .
The recently cloned cDNA of the mouse obese (ob) gene encodes a 167-amino acid protein that is highly conserved in a number of vertebrate species (13) . The presence of ob gene transcript only in white adipose tissue, an amino-terminal signal sequence consistent with secretion of mature protein, and the hyperphagia of the ob/ob mouse, which produces a defective ob protein, has led to the suggestion that this protein may be the long-sought adipose satiety factor ( 14) . However, the ob/ob mouse also exhibits defects in thermogenesis, fat metabolism, insulin secretion, and fertility ( 15) . To the extent that this pleotypic phenotype is explained by a defect in a single gene, the effect of the ob protein on feeding may be indirect.
To determine whether the ob gene product potentially acts as a satiety factor, we injected recombinant ob protein intraperitoneally into ob/ob mice and followed daily food intake and body weight. Decreased food intake was observed over a 24-h period with a clear dose-dependent relationship to administered ob protein. Repeated daily injections of ob protein led to weight loss and reductions in fasting insulin and glucose levels. The satiety effect of recombinant ob protein appeared not to require any cofactor produced by adipose tissue, nor was posttranslational processing by a mammalian cell required for activity. The effect of modification of the amino terminus of the ob protein to prolong its biological action was also explored.
Methods
Expression and purification of recombinant ob protein Cloning of ob cDNA. Murine ob cDNA was obtained by PCR of db/ db mouse adipose tissue cDNA using primers designed from the terminal coding regions of the published cDNA sequence (13) . A second round of PCR was used to add flanking EcoRl and Sall restriction sites to permit directional insertion into the pDX expression vector (16) 
Statistics
All results were expressed as mean±standard error (SE), and comparisons were made using two-tailed paired or unpaired t tests, as appropriate, with a significance level of 0.05%.
Results
Northern analysis was performed to verify successful cotransfection of BHK cells with plasmids containing cDNA for the ob protein and selectable marker. No ob message was detected in control BHK cells transfected with ZEM229R alone, whereas a high level of ob mRNA was evident in cells transfected with both ZEM22R and the pDX ob vector (Fig. 1 A) . The smaller size of ob m]RNA in the BHK system compared with message detected in rat adipose tissue (Fig. 1 A) reflects deletion of the ob cDNA 3' untranslated region in the recombinant construct. A silver-stained reducing gel of hydroxyapatite column-purified medium conditioned by control and recombinant BHK cells is shown in Fig. 1 represents 63% of the total protein in purified medium conditioned by recombinant BHK cells. Western analyses performed on both nonreducing and reducing gels of unprocessed media conditioned by recombinant BHK cells are shown in Fig. 1 C. It can be seen that both monomeric and dimeric forms of ob protein are produced, whereas only the monomeric form of mature 16-kD ob protein is evident in medium conditioned by microdissected fa/fa rat adipose tissue. Western analysis of recombinant BHK cell conditioned medium before and after hydroxyapatite column purification is shown in Fig. 1 D. This purification step removes dimeric ob protein, resulting in material that more closely resembles the naturally produced ob gene product.
Hydroxyapatite column-purified monomeric BHK ob protein decreased 24-h chow consumption by ob/ob mice (Fig.  2) . A progressive reduction of chow intake from baseline was seen with increasing dosage of protein. The difference in response to injections of ob protein and injections of ZEM229R control conditioned medium became significant at a dose of 10 jig (81±6.8% of control, P = 0.04) and appeared to be nearly maximal at a dose of 100 tzg (29±7.7% of control, P < 0.0001).
Administration of purified dimeric ob protein at doses of [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Og produced an insignificant decrease in feeding to 98 ±4.4% of baseline (n = 5).
If hyperphagia and obesity in the ob/ob mouse are due to lack of functional ob protein, and the normal route by which the ob protein acts is through the circulation, then chronic administration of recombinant ob protein should lead to reductions in feeding and body weight in ob/ob mice. These predictions were verified during 2 wk of daily ob protein injections (Fig.  3 A) , with an 11±1.6% decrease in body weight (P = 0.0009) and a maximal suppression of feeding to 26±4.9% of baseline (P < 0.0001). The effect of injections on chow intake and body weight dissipated rapidly after the test period. Daily injection of ZEM229R conditioned medium to control animals had no effect on feeding or weight gain (Fig. 3 B) . Serum insulin and glucose levels decreased significantly after 2 wk of ob protein administration in test animals, but remained elevated in control animals (Table I) .
To determine whether the effect of ob protein is enhanced by interaction with other adipocyte secretory products, microdissected ob/ob mouse adipose tissue was incubated in medium previously conditioned by either control BHK Figure 3 . Effect of daily administration of recombinant ob protein or control medium on body weight (squares, left axes) and chow consumption (circles, right axes) of ob/ob mice. Animals received daily 1-ml injections of PBS except during the periods indicated by the bars when injections were changed to 80 ,g of recombinant ob protein in 1 ml of medium (A, n = 6) or 1 ml of equally concentrated nonrecombinant control medium (B, n = 3). All points represent mean±SE (some error bars are hidden within symbols).
volumes were chosen such that a comparable amount of recombinant BHK cell conditioned medium would produce a measurable but submaximal response in the feeding assay after our standard 30-fold concentration. Microdissected adipose tissue from the db/db mouse, which produces circulating adiposerelated satiety factor (9, 10), was incubated in the same volume ratio of unconditioned medium and used as a control to assure physiological secretory function of adipose tissue under the chosen experimental conditions. Incubation of ob/ob mouse adipose tissue in medium containing recombinant ob protein did not enhance the ability of that medium to suppress feeding in test animals (Table II) . Medium conditioned by db/db mouse adipose tissue produced a significant feeding suppression which exceeded the response observed to medium conditioned by obi (Fig. 4) .
To determine whether posttranslational processing by a mammalian cell is essential for activity, recombinant ob protein cleaved from the E. coli fusion product and refolded in vitro was administered to nine ob/ob assay animals at a dose of 50 pg per animal. This material produced a suppression of 24-h chow consumption to 70±3.2% of baseline as compared with 101±4.1% of baseline observed in nine animals that received control buffer injections (P < 0.0001). Amino-terminal hexahistidine-tagged recombinant BHK cell ob protein that had been purified to near homogeneity over a nickle column was also assayed. The latter material at a dose of 25 ,ug suppressed 24-h chow consumption to 70±6.2% of baseline (n = 6) as compared with 100±4.0% of baseline in six animals that received control buffer injections (P = 0.002). The effect of a single injection of tagged ob protein on feeding was significantly pro-12 4400- longed relative to the effect of unmodified ob protein produced by BHK cells (Fig. 5) .
Discussion
Abundant evidence from animal experimentation suggests that a stable circulating adipose-related satiety factor plays an important role in the regulation of body fat content (6) . This factor could be a molecule such as insulin that circulates at a level proportional to total adipose mass but is not produced by adipocytes (19) . Alternatively, adipocytes could directly secrete a substance that inhibits feeding when the total body triglyceride store becomes excessive. Support for the latter hypothesis has been limited by the technical difficulty of using feeding behavior as an assay to guide purification of the putative molecule from adipose tissue (11, 12) . The protein product of the recently cloned ob gene is an excellent candidate for an adipose-related satiety factor by virtue of its predicted structural features and natural source ( 13, 14) . The goals of the present study were to produce recombinant ob protein in sufficient quantity to assess its effect on feeding and body weight and to explore the possibility that posttranslational processing or cofactors produced by adipose tissue were required for any observed activity.
With regard to the first goal, expression of ob protein by recombinant BHK cells was sufficient to demonstrate immunoreactive protein in unconcentrated conditioned culture medium and bioactive protein after 10-30-fold concentration of conditioned medium by ultrafiltration. Western analysis of recombinant BHK medium under reducing and nonreducing conditions demonstrated both mature ob protein of 16 kD and a species of 32 kD consistent with disulfide bond formation between two ob molecules. Broad bands or doublets occasionally seen by Western analysis suggested the existence of additional conformational forms of ob protein, but the agreement between observed and calculated molecular weights argued against extensive glycosylation. Although concentrated recombinant BHK medium suppressed feeding in ob/ob mice without further processing, monomeric ob protein appeared to be the predominant form secreted by culturedfa/fa rat adipose tissue. Accordingly, hydroxyapatite chromatography was used to remove dimeric ob protein from conditioned medium before performing feeding dose-response studies.
Animals were required to display a daily variation in 24-h chow intake of 10% or less for inclusion in the current feeding assay. A difference in chow intake of up to 20% would, therefore, be expected in response to the same material given on two separate occasions even if all other variables affecting feeding were constant. Despite this inherent imprecision, recombinant ob protein clearly inhibited 24-h chow intake by ob/ob mice in a dose-dependent manner. All animals used in the feeding assay remained active, groomed normally, and demonstrated steady weight gain after test injections, suggesting that the observed decreases in chow consumption were not due to toxicity of the ob protein preparation. Formal testing for an aversive effect of injectate was not performed since ob protein is produced physiologically by adipose tissue, and identically processed medium conditioned by BHK cells transfected only with the nonrecombinant ZEM229R plasmid had no effect in the assay. The possibility that decreases in feeding reflected an immune response of sensitized animals to injected ob protein was excluded by the observation of significant feeding suppression in animals receiving test injections for the first time. It has not yet been technically possible to compare the circulating ob protein levels achieved after intraperitoneal injections in assay animals to naturally occurring levels in nonobese mice.
2 wk of daily ob protein injections resulted in progressive weight loss in assay animals as expected if the ob protein defect is the direct cause of obesity in the ob/ob mouse, and the protein exerts its effect outside the cell of origin. The animals were not killed to measure body fat content at the end of the 2-wk study period since it was felt important to verify that return to baseline weight began immediately after discontinuation of test injections as a sign that treatment produced no ill effects. Undoubtedly some fat free mass was lost along with adipose tissue as a result of treatment (20) , but activity levels and apparent wellbeing of the assay animals appeared unchanged or even improved. The highly significant decreases in both insulin and glucose levels in animals that received test injections demonstrated that improved insulin sensitivity accompanied the weight loss induced by recombinant ob protein. Although the cumulative reduction in chow intake appeared to account for most of the weight loss observed in test animals, it is possible that an increase in thermogenesis induced by ob protein administration contributed to the negative energy balance.
In rodents that have undergone weight loss as a result of food restriction, marked hyperphagia is observed immediately after return to ad libitum feeding and persists until body weight has been completely regained (21) . The notable absence of rebound hyperphagia after 2 wk of ob protein administration in the current study indicates that the effect of ob protein is actually much more sustained than Fig. 3 (9, 10) .
It has been reported that the ob mRNA level in ob/ob mouse fat is greatly increased relative to the level observed in fat of lean littermates (13) . This could be due to linkage of ob gene transcription to fat cell size or triglyceride synthesis by metabolic signals yet to be described. Alternatively, there could be release of end product inhibition of ob gene transcription in the ob/ob mouse due to the production of a defective ob protein.
The latter possibility suggests that the ob protein might interact with a receptor on the adipocyte to alter its own level of expression. Our failure to detect any alteration in ob mRNA level in adipose tissue fragments cultured in the presence of recombinant ob protein argues against such an autocrine feedback mechanism. The possibility that intracellular ob protein might downregulate ob gene transcription cannot be excluded by our data.
The finding that recombinant ob protein produced in a prokaryotic system retains the ability to suppress feeding demonstrates that posttranslational modification by a mammalian cell is not absolutely required for activity. The lower activity of ob protein produced by E. coli relative to BHK cells may reflect incorrect refolding of a portion of the prokaryotic material during the reoxidation step. Addition of a hexahistidine tag to the amino terminus of the ob protein created the possibility of a onestep purification of recombinant material over a metal chelation column. Rather than inactivating the molecule, this modification resulted in a prolonged suppression of feeding after administration to ob/ob mice. The altered kinetics of the response to tagged ob protein might be due to resistance to degradation in the serum or stabilization of the interaction of ob protein and its receptor.
Our results demonstrate a direct effect of the ob protein to suppress feeding and suggest that this molecule plays a critical role in regulating total body fat content. If the circulating ob protein level proves to be the dominant signal interpreted by the central nervous system to reflect energy stores, then exogenous administration of this substance may be useful in treating some forms of human obesity. Recent reports that adipocyte ob mRNA levels are elevated in obese rats (24) and humans (25) raise the possibility that obesity is accompanied by a relative insensitivity to the ob protein. Therapeutic use of exogenous ob protein may, therefore, not be possible in all individuals or may require large doses of protein to overcome resistance to this agent at a receptor or postreceptor level.
